Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hans-Georg Rammensee

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Living Beings

Genes & Molecular Sequences

Amino Acid Sequence

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Wahlström Jan; Dengjel Jörn; Winqvist Ola; Targoff Ira; Persson Bengt; Duyar Hüseyin; Rammensee Hans-Georg; Eklund Anders; Weissert Robert; Grunewald Johan
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis.
Attig Sebastian; Hennenlotter Jörg; Pawelec Graham; Klein Gerd; Koch Sven D; Pircher Hanspeter; Feyerabend Susan; Wernet Dorothee; Stenzl Arnulf; Rammensee Hans-Georg; Gouttefangeas Cécile
Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.
Fissolo Nicolas; Haag Sabrina; de Graaf Katrien L; Drews Oliver; Stevanovic Stefan; Rammensee Hans Georg; Weissert Robert
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans-Georg Rammensee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Wahlström Jan; Dengjel Jörn; Winqvist Ola; Targoff Ira; Persson Bengt; Duyar Hüseyin; Rammensee Hans-Georg; Eklund Anders; Weissert Robert; Grunewald Johan
Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis.
Clinical immunology (Orlando, Fla.) 2009;133(3):353-63.
2009: Attig Sebastian; Hennenlotter Jörg; Pawelec Graham; Klein Gerd; Koch Sven D; Pircher Hanspeter; Feyerabend Susan; Wernet Dorothee; Stenzl Arnulf; Rammensee Hans-Georg; Gouttefangeas Cécile
Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.
Cancer research 2009;69(21):8412-9.
2009: Fissolo Nicolas; Haag Sabrina; de Graaf Katrien L; Drews Oliver; Stevanovic Stefan; Rammensee Hans Georg; Weissert Robert
Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.
Molecular & cellular proteomics : MCP 2009;8(9):2090-101.
2009: Stickel Juliane Sarah; Weinzierl Andreas O; Hillen Nina; Drews Oliver; Schuler Mathias M; Hennenlotter Jörg; Wernet Dorothee; Müller Claudia A; Stenzl Arnulf; Rammensee Hans-Georg; Stevanovic Stefan
HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
Cancer immunology, immunotherapy : CII 2009;58(9):1407-17.
2009: Diekmann Jan; Adamopoulou Eleni; Beck Olaf; Rauser Georg; Lurati Sarah; Tenzer Stefan; Einsele Hermann; Rammensee Hans-Georg; Schild Hansjörg; Topp Max S
Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(3):1587-97.
2009: Meyer Verena S; Drews Oliver; Günder Marc; Hennenlotter Jörg; Rammensee Hans-Georg; Stevanovic Stefan
Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands.
Journal of proteome research 2009;8(7):3666-74.
2009: Weide Benjamin; Pascolo Steve; Scheel Birgit; Derhovanessian Evelyna; Pflugfelder Annette; Eigentler Thomas K; Pawelec Graham; Hoerr Ingmar; Rammensee Hans-Georg; Garbe Claus
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(5):498-507.
2009: Löb Stefan; Königsrainer Alfred; Rammensee Hans-Georg; Opelz Gerhard; Terness Peter
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Nature reviews. Cancer 2009;9(6):445-52.
2009: Feyerabend Susan; Stevanovic Stefan; Gouttefangeas Cécile; Wernet Dorothee; Hennenlotter Jörg; Bedke Jens; Dietz Klaus; Pascolo Steve; Kuczyk Markus; Rammensee Hans-Georg; Stenzl Arnulf
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.
The Prostate 2009;69(9):917-27.
2009: Asemissen Anne Marie; Haase Doreen; Stevanovic Stefan; Bauer Sandra; Busse Antonia; Thiel Eckhard; Rammensee Hans-Georg; Keilholz Ulrich; Scheibenbogen Carmen
Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(4):370-5.
2009: Kuttruff Sabrina; Koch Sven; Kelp Alexandra; Pawelec Graham; Rammensee Hans-Georg; Steinle Alexander
NKp80 defines and stimulates a reactive subset of CD8 T cells.
Blood 2009;113(2):358-69.
2009: Otz T; Grosse-Hovest L; Hofmann M; Rammensee H-G; Jung G
A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(1):71-7.
2009: Löb Stefan; Königsrainer Alfred; Zieker Derek; Brücher Björn L D M; Rammensee Hans-Georg; Opelz Gerhard; Terness Peter
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.
Cancer immunology, immunotherapy : CII 2009;58(1):153-7.
2008: Hillen Nina; Mester Gabor; Lemmel Claudia; Weinzierl Andreas O; Müller Margret; Wernet Dorothee; Hennenlotter Jörg; Stenzl Arnulf; Rammensee Hans-Georg; Stevanovic Stefan
Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype.
European journal of immunology 2008;38(11):2993-3003.
2008: Kloss Mercedes; Decker Patrice; Baltz Katrin M; Baessler Tina; Jung Gundram; Rammensee Hans-Georg; Steinle Alexander; Krusch Matthias; Salih Helmut R
Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(10):6711-9.
2008: Meyer Verena S; Kastenmuller Wolfgang; Gasteiger Georg; Franz-Wachtel Mirita; Lamkemeyer Tobias; Rammensee Hans-Georg; Stevanovic Stefan; Sigurdardottir Dagmar; Drexler Ingo
Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(9):6371-83.
2008: Yokoyama Yuko; Grünebach Frank; Schmidt Susanne M; Heine Annkristin; Häntschel Maik; Stevanovic Stefan; Rammensee Hans-Georg; Brossart Peter
Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5503-11.
2008: Weinzierl Andreas O; Rudolf Despina; Maurer Dominik; Wernet Dorothee; Rammensee Hans-Georg; Stevanovic Stefan; Klingel Karin
Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses.
The Journal of general virology 2008;89(Pt 9):2090-7.
2008: Waldhauer Inja; Goehlsdorf Dennis; Gieseke Friederike; Weinschenk Toni; Wittenbrink Mareike; Ludwig Andreas; Stevanovic Stefan; Rammensee Hans-Georg; Steinle Alexander
Tumor-associated MICA is shed by ADAM proteases.
Cancer research 2008;68(15):6368-76.
2008: Weinzierl Andreas Oliver; Szalay Gudrun; Wolburg Hartwig; Sauter Martina; Rammensee Hans-Georg; Kandolf Reinhard; Stevanovic Stefan; Klingel Karin
Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.
Journal of virology 2008;82(16):8149-60.
2008: Feldhahn Magdalena; Thiel Philipp; Schuler Mathias M; Hillen Nina; Stevanovic Stefan; Rammensee Hans-Georg; Kohlbacher Oliver
EpiToolKit--a web server for computational immunomics.
Nucleic acids research 2008;36(Web Server issue):W519-22.
2008: Weinzierl Andreas O; Rudolf Despina; Hillen Nina; Tenzer Stefan; van Endert Peter; Schild Hansjörg; Rammensee Hans-Georg; Stevanovic Stefan
Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
European journal of immunology 2008;38(6):1503-10.
2008: Weinzierl Andreas O; Maurer Dominik; Altenberend Florian; Schneiderhan-Marra Nicole; Klingel Karin; Schoor Oliver; Wernet Dorothee; Joos Thomas; Rammensee Hans-Georg; Stevanovic Stefan
A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.
Cancer research 2008;68(7):2447-54.
2008: Schatz Mark M; Peters Björn; Akkad Nadja; Ullrich Nina; Martinez Alejandra Nacarino; Carroll Oliver; Bulik Sascha; Rammensee Hans-Georg; van Endert Peter; Holzhütter Hermann-Georg; Tenzer Stefan; Schild Hansjörg
Characterizing the N-terminal processing motif of MHC class I ligands.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(5):3210-7.
2008: Herrmann Tanja; Grosse-Hovest Ludger; Otz Tina; Krammer Peter H; Rammensee Hans-Georg; Jung Gundram
Construction of optimized bispecific antibodies for selective activation of the death receptor CD95.
Cancer research 2008;68(4):1221-7.
2008: Lob Stefan; Konigsrainer Alfred; Schafer Richard; Rammensee Hans-Georg; Opelz Gerhard; Terness Peter
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.
Blood 2008;111(4):2152-4.
2008: Rudolf Despina; Silberzahn Tobias; Walter Steffen; Maurer Dominik; Engelhard Johanna; Wernet Dorothee; Bühring Hans-Jörg; Jung Gundram; Kwon Byoung S; Rammensee Hans-Georg; Stevanovic Stefan
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
Cancer immunology, immunotherapy : CII 2008;57(2):175-83.
2008: Weide Benjamin; Garbe Claus; Rammensee Hans-Georg; Pascolo Steve
Plasmid DNA- and messenger RNA-based anti-cancer vaccination.
Immunology letters 2008;115(1):33-42.
2007: Wahlström Jan; Dengjel Jörn; Persson Bengt; Duyar Hüseyin; Rammensee Hans-Georg; Stevanovic Stefan; Eklund Anders; Weissert Robert; Grunewald Johan
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.
The Journal of clinical investigation 2007;117(11):3576-82.
2007: Probst J; Weide B; Scheel B; Pichler B J; Hoerr I; Rammensee H-G; Pascolo S
Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent.
Gene therapy 2007;14(15):1175-80.
2007: Baltz Katrin M; Krusch Matthias; Bringmann Anita; Brossart Peter; Mayer Frank; Kloss Mercedes; Baessler Tina; Kumbier Ingrid; Peterfi Andrea; Kupka Susan; Kroeber Stefan; Menzel Dagmar; Radsak Markus P; Rammensee Hans-Georg; Salih Helmut R
Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(10):2442-54.
2007: Boss Cristina N; Grünebach Frank; Brauer Katharina; Häntschel Maik; Mirakaj Valbona; Weinschenk Toni; Stevanovic Stefan; Rammensee Hans-Georg; Brossart Peter
Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3347-55.
2007: Adamopoulou Eleni; Diekmann Jan; Tolosa Eva; Kuntz Gaby; Einsele Hermann; Rammensee Hans-Georg; Topp Max S
Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(9):5465-72.
2007: Weinzierl Andreas O; Lemmel Claudia; Schoor Oliver; Müller Margret; Krüger Tobias; Wernet Dorothee; Hennenlotter Jörg; Stenzl Arnulf; Klingel Karin; Rammensee Hans-Georg; Stevanovic Stefan
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface.
Molecular & cellular proteomics : MCP 2007;6(1):102-13.
2007: Gouttefangeas Cécile; Stenzl Arnulf; Stevanovic Stefan; Rammensee Hans-Georg
Immunotherapy of renal cell carcinoma.
Cancer immunology, immunotherapy : CII 2007;56(1):117-28.
2007: Röck Frank; Hadeler Karl-Peter; Rammensee Hans-Georg; Overath Peter
Quantitative analysis of mouse urine volatiles: in search of MHC-dependent differences.
PloS one 2007;2(5):e429.
2006: Asemissen Anne Marie; Keilholz Ulrich; Tenzer Stefan; Müller Margret; Walter Steffen; Stevanovic Stefan; Schild Hansjörg; Letsch Anne; Thiel Eckhard; Rammensee Hans-Georg; Scheibenbogen Carmen
Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7476-82.
2006: Rönnefarth Viktoria M; Erbacher Annika I M; Lamkemeyer Tobias; Madlung Johannes; Nordheim Alfred; Rammensee Hans-Georg; Decker Patrice
TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(11):7740-9.
2006: Rammensee Hans-Georg
Peptides made to order.
Immunity 2006;25(5):693-5.
2006: Scheel Birgit; Aulwurm Steffen; Probst Jochen; Stitz Lothar; Hoerr Ingmar; Rammensee Hans-Georg; Weller Michael; Pascolo Steve
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.
European journal of immunology 2006;36(10):2807-16.
2006: Rechtsteiner Gerd; Warger Tobias; Hofmann Matthias; Rammensee Hans-Georg; Schild Hansjörg; Radsak Markus P
Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo.
European journal of immunology 2006;36(10):2613-23.
2006: Falk Kirsten; Rötzschke Olaf; Stevanovic Stefan; Jung Günther; Rammensee Hans-Georg
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. 1991.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(5):2741-7.
2006: Decker Patrice; Kötter Ina; Klein Reinhild; Berner Beate; Rammensee Hans-Georg
Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 2006;45(9):1087-95.
2006: Warger Tobias; Hilf Nobert; Rechtsteiner Gerd; Haselmayer Philipp; Carrick Deanna M; Jonuleit Helmut; von Landenberg Philipp; Rammensee Hans-Georg; Nicchitta Christopher V; Radsak Markus P; Schild Hansjörg
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses.
The Journal of biological chemistry 2006;281(32):22545-53.
2006: Dengjel Jörn; Nastke Maria-Dorothea; Gouttefangeas Cécile; Gitsioudis Gitsios; Schoor Oliver; Altenberend Florian; Müller Margret; Krämer Björn; Missiou Anna; Sauter Martina; Hennenlotter Jörg; Wernet Dorothee; Stenzl Arnulf; Rammensee Hans-Georg; Klingel Karin; Stevanovic Stefan
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4163-70.
2006: Röck Frank; Mueller Sven; Weimar Udo; Rammensee Hans-Georg; Overath Peter
Comparative analysis of volatile constituents from mice and their urine.
Journal of chemical ecology 2006;32(6):1333-46.
2006: Rammensee Hans-Georg
Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer.
Immunology and cell biology 2006;84(3):290-4.
2006: Osterloh Philipp; Linkemann Kathrin; Tenzer Stefan; Rammensee Hans-Georg; Radsak Markus P; Busch Dirk H; Schild Hansjörg
Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(13):5042-7.
2006: Probst Jochen; Brechtel Sonja; Scheel Birgit; Hoerr Ingmar; Jung Günther; Rammensee Hans-Georg; Pascolo Steve
Characterization of the ribonuclease activity on the skin surface.
Genetic vaccines and therapy 2006;4():4.
2005: Schuler Mathias M; Dönnes Pierre; Nastke Maria-Dorothea; Kohlbacher Oliver; Rammensee Hans-Georg; Stevanovic Stefan
SNEP: SNP-derived epitope prediction program for minor H antigens.
Immunogenetics 2005;57(11):816-20.
2005: Grosse-Hovest Ludger; Wick Wolfgang; Minoia Rosa; Weller Michael; Rammensee Hans-Georg; Brem Gottfried; Jung Gundram
Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cells in vitro and in vivo.
International journal of cancer. Journal international du cancer 2005;117(6):1060-4.
2005: Walter Steffen; Bioley Gilles; Bühring Hans-Jörg; Koch Sven; Wernet Dorothee; Zippelius Alfred; Pawelec Graham; Romero Pedro; Stevanovic Stefan; Rammensee Hans-Georg; Gouttefangeas Cécile
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.
European journal of immunology 2005;35(10):2876-85.
2005: Krämer Björn F; Schoor Oliver; Krüger Tobias; Reichle Christian; Müller Margret; Weinschenk Toni; Hennenlotter Jörg; Stenzl Arnulf; Rammensee Hans-Georg; Stevanovic Stefan
MAGED4-expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue.
Cancer biology & therapy 2005;4(9):943-8.
2005: Krüger Tobias; Schoor Oliver; Lemmel Claudia; Kraemer Bjoern; Reichle Christian; Dengjel Jörn; Weinschenk Toni; Müller Margret; Hennenlotter Jörg; Stenzl Arnulf; Rammensee Hans-Georg; Stevanovic Stefan
Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.
Cancer immunology, immunotherapy : CII 2005;54(9):826-36.
2005: Carralot Jean-Philippe; Weide Benjamin; Schoor Oliver; Probst Jochen; Scheel Birgit; Teufel Regina; Hoerr Ingmar; Garbe Claus; Rammensee Hans-Georg; Pascolo Steve
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.
Genetic vaccines and therapy 2005;3():6.
2005: Tammiruusu A; Haveri A; Pascolo S; Lahesmaa R; Stevanovic S; Rammensee H-G; Sarvas M; Puolakkainen M; Vuola J M
Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
Scandinavian journal of immunology 2005;62(2):131-9.
2005: Teufel R; Carralot J-P; Scheel B; Probst J; Walter S; Jung G; Hoerr I; Rammensee H-G; Pascolo S
Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen-specific cytotoxic T-lymphocytes in vitro.
Cellular and molecular life sciences : CMLS 2005;62(15):1755-62.
2005: Dittmann Jasmin; Keller-Matschke Karin; Weinschenk Toni; Kratt Thomas; Heck Tobias; Becker Horst-Dieter; Stevanovic Stefan; Rammensee Hans-Georg; Gouttefangeas Cécile
CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.
Cancer immunology, immunotherapy : CII 2005;54(8):750-8.
2005: Herter Sylvia; Osterloh Philipp; Hilf Norbert; Rechtsteiner Gerd; Höhfeld Jörg; Rammensee Hans-Georg; Schild Hansjörg
Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):891-8.
2005: Wiemann Katrin; Mittrücker Hans-Willi; Feger Ute; Welte Stefan A; Yokoyama Wayne M; Spies Thomas; Rammensee Hans-Georg; Steinle Alexander
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):720-9.
2005: Schilbach Karin; Kerst Gunter; Walter Steffen; Eyrich Matthias; Wernet Dorothee; Handgretinger Rupert; Xie Weidong; Rammensee Hans-Georg; Müller Ingo; Bühring Hans-Jörg; Niethammer Dietrich
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
Blood 2005;106(1):144-9.
2005: Dengjel Jörn; Schoor Oliver; Fischer Rainer; Reich Michael; Kraus Marianne; Müller Margret; Kreymborg Katharina; Altenberend Florian; Brandenburg Jens; Kalbacher Hubert; Brock Roland; Driessen Christoph; Rammensee Hans-Georg; Stevanovic Stefan
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(22):7922-7.
2005: Tenzer S; Peters B; Bulik S; Schoor O; Lemmel C; Schatz M M; Kloetzel P-M; Rammensee H-G; Schild H; Holzhütter H-G
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding.
Cellular and molecular life sciences : CMLS 2005;62(9):1025-37.
2005: Scheel Birgit; Teufel Regina; Probst Jochen; Carralot Jean-Philippe; Geginat Jens; Radsak Markus; Jarrossay David; Wagner Hermann; Jung Günther; Rammensee Hans-Georg; Hoerr Ingmar; Pascolo Steve
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.
European journal of immunology 2005;35(5):1557-66.
2005: Carralot Jean-Philippe; Dumrese Claudia; Wessel Ralf; Riessen Reimer; Autenrieth Ingo; Walter Steffen; Schoor Oliver; Stevanovic Stefan; Rammensee Hans-Georg; Pascolo Steve
CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients.
International immunology 2005;17(5):591-7.
2005: Decker Patrice; Singh-Jasuja Harpreet; Haager Sabine; Kötter Ina; Rammensee Hans-Georg
Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3326-34.
2005: Pascolo Steve; Ginhoux Florent; Laham Nihay; Walter Steffen; Schoor Oliver; Probst Jochen; Rohrlich Pierre; Obermayr Florian; Fisch Paul; Danos Olivier; Ehrlich Rachel; Lemonnier Francois A; Rammensee Hans-Georg
The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells.
International immunology 2005;17(2):117-22.
2005: Dengjel Jörn; Rammensee Hans-Georg; Stevanovic Stefan
Glycan side chains on naturally presented MHC class II ligands.
Journal of mass spectrometry : JMS 2005;40(1):100-4.
2005: Nastke M-D; Herrgen L; Walter S; Wernet D; Rammensee H-G; Stevanovic S
Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
Cellular and molecular life sciences : CMLS 2005;62(1):77-86.
2005: Ramirez Sabina Rayo; Singh-Jasuja Harpreet; Warger Tobias; Braedel-Ruoff Sibylla; Hilf Norbert; Wiemann Katrin; Rammensee Hans-Georg; Schild Hansjörg
Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response.
Cell stress & chaperones 2005;10(3):221-9.
2004: Dengjel Jörn; Decker Patrice; Schoor Oliver; Altenberend Florian; Weinschenk Toni; Rammensee Hans-Georg; Stevanovic Stefan
Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectrometry.
European journal of immunology 2004;34(12):3644-51.
2004: Carralot J-P; Probst J; Hoerr I; Scheel B; Teufel R; Jung G; Rammensee H-G; Pascolo S
Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines.
Cellular and molecular life sciences : CMLS 2004;61(18):2418-24.
2004: Probst Jochen; Blumenthal Sibylle G; Tenzer Stefan; Weinschenk Toni; Dittmer Jürgen; Schoor Oliver; Six Adrien; Rammensee Hans-Georg; Pascolo Steve
A conserved sequence in the mouse variable T cell receptor alpha recombination signal sequence 23-bp spacer can affect recombination.
European journal of immunology 2004;34(8):2179-90.
2004: Hofmann Matthias; Radsak Markus; Rechtsteiner Gerd; Wiemann Katrin; Günder Marc; Bien-Gräter Ursula; Offringa Rienk; Toes René E M; Rammensee Hans-Georg; Schild Hansjörg
T cell avidity determines the level of CTL activation.
European journal of immunology 2004;34(7):1798-806.
2004: Neumann Frank; Wagner Claudia; Kubuschok Boris; Stevanovic Stefan; Rammensee Hans-Georg; Pfreundschuh Michael
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes.
Cancer immunology, immunotherapy : CII 2004;53(7):589-99.
2004: Schag Kerstin; Schmidt Susanne M; Müller Martin R; Weinschenk Toni; Appel Silke; Weck Markus M; Grünebach Frank; Stevanovic Stefan; Rammensee Hans-Georg; Brossart Peter
Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3658-66.
2004: Radsak Markus P; Salih Helmut R; Rammensee Hans-Georg; Schild Hansjörg
Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(8):4956-63.
2004: Lemmel Claudia; Weik Steffen; Eberle Ute; Dengjel Jörn; Kratt Thomas; Becker Horst-Dieter; Rammensee Hans-Georg; Stevanovic Stefan
Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling.
Nature biotechnology 2004;22(4):450-4.
2004: Kircher Brigitte; Wolf Maria; Stevanovic Stefan; Rammensee Hans-Georg; Grubeck-Loebenstein Beatrix; Gastl Günther; Nachbaur David
Hematopoietic lineage-restricted minor histocompatibility antigen HA-1 in graft-versus-leukemia activity after donor lymphocyte infusion.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(2):156-60.
2004: Singh-Jasuja Harpreet; Emmerich Niels P N; Rammensee Hans-Georg
The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy.
Cancer immunology, immunotherapy : CII 2004;53(3):187-95.
2004: Schmidt Susanne M; Schag Kerstin; Müller Martin R; Weinschenk Toni; Appel Silke; Schoor Oliver; Weck Markus M; Grünebach Frank; Kanz Lothar; Stevanovic Stefan; Rammensee Hans-Georg; Brossart Peter
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
Cancer research 2004;64(3):1164-70.
2004: Scheel Birgit; Braedel Sybilla; Probst Jochen; Carralot Jean-Philippe; Wagner Hermann; Schild Hansjorg; Jung Günther; Rammensee Hans-Georg; Pascolo Steve
Immunostimulating capacities of stabilized RNA molecules.
European journal of immunology 2004;34(2):537-47.
2004: Rammensee Hans-Georg
Immunology: protein surgery.
Nature 2004;427(6971):203-4.
2004: Tenzer Stefan; Stoltze Lars; Schönfisch Birgitt; Dengjel Jörn; Müller Margret; Stevanovic Stefan; Rammensee Hans-Georg; Schild Hansjörg
Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(2):1083-91.
2003: Friese Manuel A; Platten Michael; Lutz Stefan Z; Naumann Ulrike; Aulwurm Steffen; Bischof Felix; Bühring Hans-Jörg; Dichgans Johannes; Rammensee Hans-Georg; Steinle Alexander; Weller Michael
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Cancer research 2003;63(24):8996-9006.
2003: Schoor Oliver; Weinschenk Toni; Hennenlotter Jörg; Corvin Stefan; Stenzl Arnulf; Rammensee Hans-Georg; Stevanovic Stefan
Moderate degradation does not preclude microarray analysis of small amounts of RNA.
BioTechniques 2003;35(6):1192-6, 1198-201.
2003: Wagner Claudia; Neumann Frank; Kubuschok Boris; Regitz Evi; Mischo Axel; Stevanovic Stefan; Friedrich Michael; Schmidt Werner; Rammensee Hans-Georg; Pfreundschuh Michael
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():18.
2003: Walter Steffen; Herrgen Leah; Schoor Oliver; Jung Gundram; Wernet Dorothee; Bühring Hans-Jörg; Rammensee Hans-Georg; Stevanovic Stefan
Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(10):4974-8.
2003: Hebart Holger; Rauser Georg; Stevanovic Stefan; Haenle Claire; Nussbaum Alexander K; Meisner Christoph; Bissinger Alfred L; Tenzer Stefan; Jahn Gerhard; Loeffler Juergen; Rammensee Hans-Georg; Schild Hansjörg; Einsele Hermann
A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation.
Experimental hematology 2003;31(10):966-73.
2003: Salih Helmut Rainer; Antropius Holger; Gieseke Friederike; Lutz Stefan Zoltan; Kanz Lothar; Rammensee Hans-Georg; Steinle Alexander
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.
Blood 2003;102(4):1389-96.
2003: Decker Patrice; Wolburg Hartwig; Rammensee Hans-Georg
Nucleosomes induce lymphocyte necrosis.
European journal of immunology 2003;33(7):1978-87.
2003: Grosse-Hovest Ludger; Hartlapp Ingo; Marwan Wolfgang; Brem Gottfried; Rammensee Hans-Georg; Jung Gundram
A recombinant bispecific single-chain antibody induces targeted, supra-agonistic CD28-stimulation and tumor cell killing.
European journal of immunology 2003;33(5):1334-40.
2003: Radsak Markus P; Hilf Norbert; Singh-Jasuja Harpreet; Braedel Sibylla; Brossart Peter; Rammensee Hans-Georg; Schild Hansjoerg
The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions.
Blood 2003;101(7):2810-5.
2003: Stoltze L; Rezaei H; Jung G; Grosclaude J; Debey P; Schild H; Rammensee H G
CD4+ T cell-mediated immunity against prion proteins.
Cellular and molecular life sciences : CMLS 2003;60(3):629-38.
2003: Welte Stefan A; Sinzger Christian; Lutz Stefan Z; Singh-Jasuja Harpreet; Sampaio Kerstin Laib; Eknigk Ute; Rammensee Hans-Georg; Steinle Alexander
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
European journal of immunology 2003;33(1):194-203.
2003: Drexler Ingo; Staib Caroline; Kastenmuller Wolfgang; Stevanovic Stefan; Schmidt Burkhard; Lemonnier François A; Rammensee Hans-Georg; Busch Dirk H; Bernhard Helga; Erfle Volker; Sutter Gerd
Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(1):217-22.
2003: Lang K S; Weigert C; Braedel S; Fillon S; Palmada M; Schleicher E; Rammensee H-G; Lang F
Inhibition of interferon-gamma expression by osmotic shrinkage of peripheral blood lymphocytes.
American journal of physiology. Cell physiology 2003;284(1):C200-8.
2003: Hakenberg Jörg; Nussbaum Alexander K; Schild Hansjörg; Rammensee Hans-Georg; Kuttler Christina; Holzhütter Hermann-Georg; Kloetzel Peter-M; Kaufmann Stefan H E; Mollenkopf Hans-Joachim
MAPPP: MHC class I antigenic peptide processing prediction.
Applied bioinformatics 2003;2(3):155-8.
2003: Rammensee Hans-Georg
Immunoinformatics: bioinformatic strategies for better understanding of immune function. Introduction.
Novartis Foundation symposium 2003;254():1-2.
2003: Kleist Christian; Arnold-Schild Danièle; Welschof Martin; Finger Martina; Opelz Gerhard; Rammensee Hans-Georg; Schild Hansjörg; Terness Peter
Single-chain Fv-based affinity purification of the cellular stress protein gp96 for vaccine development.
Methods in molecular biology (Clifton, N.J.) 2003;207():393-420.
2002: Yoshida Kenji; Martin Tracy; Yamamoto Ken; Dobbs Cathleen; Münz Christian; Kamikawaji Nobuhiro; Nakano Naoko; Rammensee Hans-Georg; Sasazuki Takehiko; Haskins Kathryn; Kikutani Hitoshi
Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.
International immunology 2002;14(12):1439-47.
2002: Rammensee Hans-Georg; Weinschenk Toni; Gouttefangeas Cécile; Stevanovic Stefan
Towards patient-specific tumor antigen selection for vaccination.
Immunological reviews 2002;188():164-76.
2002: Weinschenk Toni; Gouttefangeas Cécile; Schirle Markus; Obermayr Florian; Walter Steffen; Schoor Oliver; Kurek Raffael; Loeser Wolfgang; Bichler Karl-Horst; Wernet Dorothee; Stevanovic Stefan; Rammensee Hans-Georg
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.
Cancer research 2002;62(20):5818-27.
2002: Salih Helmut R; Rammensee Hans-Georg; Steinle Alexander
Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(8):4098-102.
2002: Rammensee Hans-Georg
Survival of the fitters.
Nature 2002;419(6906):443-5.
2002: Münz Christian; Hofmann Matthias; Yoshida Kenji; Moustakas Antonis K; Kikutani Hitoshi; Stevanoviç Stefan; Papadopoulos George K; Rammensee Hans-Georg
Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7).
European journal of immunology 2002;32(8):2105-16.
2002: Sarén Anne; Pascolo Steve; Stevanovic Stefan; Dumrese Tilman; Puolakkainen Mirja; Sarvas Matti; Rammensee Hans-Georg; Vuola Jenni M
Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes.
Infection and immunity 2002;70(7):3336-43.
2002: Lang K S; Moris A; Gouttefangeas C; Walter S; Teichgräber V; Miller M; Wernet D; Hamprecht K; Rammensee H G; Stevanovic S
High frequency of human cytomegalovirus (HCMV)-specific CD8+ T cells detected in a healthy CMV-seropositive donor.
Cellular and molecular life sciences : CMLS 2002;59(6):1076-80.
2002: Kircher Brigitte; Stevanovic Stefan; Urbanek Martina; Mitterschiffthaler Andrea; Rammensee Hans-Georg; Grünewald Kurt; Gastl Günther; Nachbaur David
Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion.
British journal of haematology 2002;117(4):935-9.
2002: Einsele Hermann; Roosnek Eddy; Rufer Nathalie; Sinzger Christian; Riegler Susanne; Löffler Jürgen; Grigoleit Ulrich; Moris Arnaud; Rammensee Hans-Georg; Kanz Lothar; Kleihauer Annette; Frank Friederike; Jahn Gerhard; Hebart Holger
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.
Blood 2002;99(11):3916-22.
2002: Vabulas Ramunas M; Braedel Sibylla; Hilf Norbert; Singh-Jasuja Harpreet; Herter Sylvia; Ahmad-Nejad Parviz; Kirschning Carsten J; Da Costa Clarissa; Rammensee Hans-Georg; Wagner Hermann; Schild Hansjorg
The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway.
The Journal of biological chemistry 2002;277(23):20847-53.
2002: Maier Jan T; Haug Markus; Föll Jürgen L; Beck Hermann; Kalbacher Hubert; Rammensee Hans-Georg; Dannecker Günther E
Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis.
Immunogenetics 2002;54(2):67-73.
2002: Hebart Holger; Daginik Senay; Stevanovic Stefan; Grigoleit Ulrich; Dobler Andrea; Baur Manuela; Rauser Georg; Sinzger Christian; Jahn Gerhard; Loeffler Juergen; Kanz Lothar; Rammensee Hans-Georg; Einsele Hermann
Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
Blood 2002;99(10):3830-7.
2002: Hilf Norbert; Singh-Jasuja Harpreet; Schwarzmaier Petra; Gouttefangeas Cécile; Rammensee Hans-Georg; Schild Hansjörg
Human platelets express heat shock protein receptors and regulate dendritic cell maturation.
Blood 2002;99(10):3676-82.
2002: Wischhusen Jörg; Jung Gundram; Radovanovic Ivan; Beier Christoph; Steinbach Joachim P; Rimner Andreas; Huang Huatao; Schulz Jörg B; Ohgaki Hiroko; Aguzzi Adriano; Rammensee Hans-Georg; Weller Michael
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
Cancer research 2002;62(9):2592-9.
2002: Scheibenbogen Carmen; Sun Yuansheng; Keilholz Ulrich; Song Mingxia; Stevanovic Stefan; Asemissen Anne Marie; Nagorsen Dirk; Thiel Eckhard; Rammensee Hans-Georg; Schadendorf Dirk
Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.
International journal of cancer. Journal international du cancer 2002;98(3):409-14.
2002: Lang K S; Fillon S; Schneider D; Rammensee H-G; Lang F
Stimulation of TNF alpha expression by hyperosmotic stress.
Pflügers Archiv : European journal of physiology 2002;443(5-6):798-803.
2002: Ayyoub Maha; Stevanovic Stefan; Sahin Ugur; Guillaume Philippe; Servis Catherine; Rimoldi Donata; Valmori Danila; Romero Pedro; Cerottini Jean-Charles; Rammensee Hans-Georg; Pfreundschuh Michael; Speiser Daniel; Lévy Frédéric
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1717-22.
2001: Montag S; Frank M; Ulmer H; Wernet D; Göpel W; Rammensee H G
"Electronic nose" detects major histocompatibility complex-dependent prerenal and postrenal odor components.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(16):9249-54.
2001: Toes R E; Nussbaum A K; Degermann S; Schirle M; Emmerich N P; Kraft M; Laplace C; Zwinderman A; Dick T P; Müller J; Schönfisch B; Schmid C; Fehling H J; Stevanovic S; Rammensee H G; Schild H
Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.
The Journal of experimental medicine 2001;194(1):1-12.
2001: Moris A; Wernet D; Stevanovic S; Rammensee H G
The peptide-specific alloreactive human T cell repertoire varies largely between individuals and is not extended in HLA-A*0205--anti-HLA-A*0201 pairings.
International immunology 2001;13(7):863-70.
2001: Gouttefangeas C; Eberle M; Ruck P; Stark M; Müller J E; Becker H D; Rammensee H G; Pinocy J
Functional T lymphocytes infiltrate implanted polyvinyl alcohol foams during surgical wound closure therapy.
Clinical and experimental immunology 2001;124(3):398-405.
2001: Lang K S; Caroli C C; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee H G; Garbe C
HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
The Journal of investigative dermatology 2001;116(6):891-7.
2001: Pascolo S; Schirle M; Gückel B; Dumrese T; Stumm S; Kayser S; Moris A; Wallwiener D; Rammensee H G; Stevanovic S
A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry.
Cancer research 2001;61(10):4072-7.
2001: Kleihauer A; Grigoleit U; Hebart H; Moris A; Brossart P; Muhm A; Stevanovic S; Rammensee H G; Sinzger C; Riegler S; Jahn G; Kanz L; Einsele H
Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells.
British journal of haematology 2001;113(1):231-9.
2001: Moris A; Teichgräber V; Gauthier L; Bühring H J; Rammensee H G
Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(8):4818-21.
2001: Nussbaum A K; Kuttler C; Hadeler K P; Rammensee H G; Schild H
PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.
Immunogenetics 2001;53(2):87-94.
2001: Jung G; Grosse-Hovest L; Krammer P H; Rammensee H G
Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments.
Cancer research 2001;61(5):1846-8.
2001: Kalbus M; Fleckenstein B T; Offenhäusser M; Blüggel M; Melms A; Meyer H E; Rammensee H G; Martin R; Jung G; Sommer N
Ligand motif of the autoimmune disease-associated mouse MHC class II molecule H2-A(s).
European journal of immunology 2001;31(2):551-62.
2000: Singh-Jasuja H; Hilf N; Scherer H U; Arnold-Schild D; Rammensee H G; Toes R E; Schild H
The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.
Cell stress & chaperones 2000;5(5):462-70.
2000: Stoltze L; Schirle M; Schwarz G; Schröter C; Thompson M W; Hersh L B; Kalbacher H; Stevanovic S; Rammensee H G; Schild H
Two new proteases in the MHC class I processing pathway.
Nature immunology 2000;1(5):413-8.
2000: Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee H G; Schild H; Terness P
One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
Cancer research 2000;60(15):4175-8.
2000: Schirle M; Keilholz W; Weber B; Gouttefangeas C; Dumrese T; Becker H D; Stevanovic S; Rammensee H G
Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach.
European journal of immunology 2000;30(8):2216-25.
2000: Singh-Jasuja H; Scherer H U; Hilf N; Arnold-Schild D; Rammensee H G; Toes R E; Schild H
The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor.
European journal of immunology 2000;30(8):2211-5.
2000: Emmerich N P; Nussbaum A K; Stevanovic S; Priemer M; Toes R E; Rammensee H G; Schild H
The human 26 S and 20 S proteasomes generate overlapping but different sets of peptide fragments from a model protein substrate.
The Journal of biological chemistry 2000;275(28):21140-8.
2000: Singh-Jasuja H; Toes R E; Spee P; Münz C; Hilf N; Schoenberger S P; Ricciardi-Castagnoli P; Neefjes J; Rammensee H G; Arnold-Schild D; Schild H
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
The Journal of experimental medicine 2000;191(11):1965-74.
2000: Jekle A; Obst R; Lang F; Rammensee H G; Gulbins E
CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity.
Biochemical and biophysical research communications 2000;272(2):395-9.
2000: Gouttefangeas C; Diehl M; Keilholz W; Hörnlein R F; Stevanovic S; Rammensee H G
Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.
Blood 2000;95(10):3168-75.
2000: Kuttler C; Nussbaum A K; Dick T P; Rammensee H G; Schild H; Hadeler K P
An algorithm for the prediction of proteasomal cleavages.
Journal of molecular biology 2000;298(3):417-29.
2000: Fisch P; Moris A; Rammensee H G; Handgretinger R
Inhibitory MHC class I receptors on gammadelta T cells in tumour immunity and autoimmunity.
Immunology today 2000;21(4):187-91.
2000: Obst R; Netuschil N; Klopfer K; Stevanovic S; Rammensee H G
The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.
The Journal of experimental medicine 2000;191(5):805-12.
2000: Hoerr I; Obst R; Rammensee H G; Jung G
In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.
European journal of immunology 2000;30(1):1-7.
1999: Rammensee H; Bachmann J; Emmerich N P; Bachor O A; Stevanovic S
SYFPEITHI: database for MHC ligands and peptide motifs.
Immunogenetics 1999;50(3-4):213-9.
1999: Seeger F H; Schirle M; Keilholz W; Rammensee H G; Stevanovic S
Peptide motif of HLA-B*1510.
Immunogenetics 1999;49(11-12):996-9.
1999: Münz C; Stevanovic S; Rammensee H G
Peptide presentation and NK inhibition by HLA-G.
Journal of reproductive immunology 1999;43(2):139-55.
1999: Seeger F H; Schirle M; Gatfield J; Arnold D; Keilholz W; Nickolaus P; Rammensee H G; Stevanovic S
The HLA-A*6601 peptide motif: prediction by pocket structure and verification by peptide analysis.
Immunogenetics 1999;49(6):571-6.
1999: Brossart P; Heinrich K S; Stuhler G; Behnke L; Reichardt V L; Stevanovic S; Muhm A; Rammensee H G; Kanz L; Brugger W
Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
Blood 1999;93(12):4309-17.
1999: Nickolaus P; Rammensee H G; Zawatzky R
Molecular cloning of a macrophage-derived, interferon-inducible secreted immunoglobulin-binding protein.
European journal of immunology 1999;29(5):1504-12.
1999: Arnold-Schild D; Hanau D; Spehner D; Schmid C; Rammensee H G; de la Salle H; Schild H
Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):3757-60.
1999: Münz C; Naumann U; Grimmel C; Rammensee H G; Weller M
TGF-beta-independent induction of immunogenicity by decorin gene transfer in human malignant glioma cells.
European journal of immunology 1999;29(3):1032-40.
1999: Schild H; Arnold-Schild D; Lammert E; Rammensee H G
Stress proteins and immunity mediated by cytotoxic T lymphocytes.
Current opinion in immunology 1999;11(1):109-13.
1999: Münz C; Obst R; Osen W; Stevanovic S; Rammensee H G
Alloreactivity as a source of high avidity peptide-specific human CTL.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):25-34.
1998: Stoltze L; Dick T P; Deeg M; Pömmerl B; Rammensee H G; Schild H
Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities.
European journal of immunology 1998;28(12):4029-36.
1998: Gatfield J; Lammert E; Nickolaus P; Münz C; Rothenfusser S; Fisch P; Stevanovic S; Schild H; Rammensee H G; Arnold D
Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules.
International immunology 1998;10(11):1665-72.
1998: Gallimore A; Hombach J; Dumrese T; Rammensee H G; Zinkernagel R M; Hengartner H
A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
European journal of immunology 1998;28(10):3301-11.
1998: Nussbaum A K; Dick T P; Keilholz W; Schirle M; Stevanovic S; Dietz K; Heinemeyer W; Groll M; Wolf D H; Huber R; Rammensee H G; Schild H
Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(21):12504-9.
1998: Dick T P; Nussbaum A K; Deeg M; Heinemeyer W; Groll M; Schirle M; Keilholz W; Stevanovic S; Wolf D H; Huber R; Rammensee H G; Schild H
Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants.
The Journal of biological chemistry 1998;273(40):25637-46.
1998: Dumrese T; Stevanovic S; Seeger F H; Yamada N; Ishikawa Y; Tokunaga K; Takiguchi M; Rammensee H
HLA-A26 subtype A pockets accommodate acidic N-termini of ligands.
Immunogenetics 1998;48(5):350-3.
1998: Dick T P; Stevanovic S; Keilholz W; Ruppert T; Koszinowski U; Schild H; Rammensee H G
The making of the dominant MHC class I ligand SYFPEITHI.
European journal of immunology 1998;28(8):2478-86.
1998: Obst R; Münz C; Stevanovic S; Rammensee H G
Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire.
European journal of immunology 1998;28(8):2432-43.
1998: Seeger F H; Arnold D; Dumrese T; de la Salle H; Fricker D; Schild H; Rammensee H G; Stevanovic S
The HLA-B* 1516 motif demonstrates HLA-B-specific P2 pocket characteristics.
Immunogenetics 1998;48(2):156-60.
1998: Malcherek G; Wirblich C; Willcox N; Rammensee H G; Trowsdale J; Melms A
MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
European journal of immunology 1998;28(5):1524-33.
1998: Gallimore A; Dumrese T; Hengartner H; Zinkernagel R M; Rammensee H G
Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.
The Journal of experimental medicine 1998;187(10):1647-57.
1998: Nickolaus P; Rammensee H G; Zawatzky R
Interferon-induced expression of If-1h and If-1l alleles in Newcastle disease virus-infected mouse macrophages is associated with specific differences in viral gene transcription.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(3):187-96.
1998: Böhm C M; Hanski M L; Stefanovic S; Rammensee H G; Stein H; Taylor-Papadimitriou J; Riecken E O; Hanski C
Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by human cytotoxic T cells.
International journal of cancer. Journal international du cancer 1998;75(5):688-93.
1998: Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee H G; Kanz L; Brugger W
Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Cancer research 1998;58(4):732-6.
1997: Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee H G; Boon T; Coulie P; van der Bruggen P
Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
European journal of immunology 1997;27(12):3368-79.
1997: Arnold D; Keilholz W; Schild H; Dumrese T; Stevanovic S; Rammensee H G
Substrate specificity of cathepsins D and E determined by N-terminal and C-terminal sequencing of peptide pools.
European journal of biochemistry / FEBS 1997;249(1):171-9.
1997: Speidel K; Osen W; Faath S; Hilgert I; Obst R; Braspenning J; Momburg F; Hämmerling G J; Rammensee H G
Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses.
European journal of immunology 1997;27(9):2391-9.
1997: Arnold D; Keilholz W; Schild H; Dumrese T; Stevanovic S; Rammensee H G
Evolutionary conserved cathepsin E substrate specificity as defined by N-terminal and C-terminal sequencing of peptide pools.
Biological chemistry 1997;378(8):883-91.
1997: Arnold D; Wahl C; Faath S; Rammensee H G; Schild H
Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
The Journal of experimental medicine 1997;186(3):461-6.
1997: Lammert E; Stevanovic S; Brunner J; Rammensee H G; Schild H
Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum.
European journal of immunology 1997;27(7):1685-90.
1997: Jochmus I; Osen W; Altmann A; Buck G; Hofmann B; Schneider A; Gissmann L; Rammensee H G
Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
The Journal of general virology 1997;78 ( Pt 7)():1689-95.
1997: Scheibenbogen C; Lee K H; Stevanovic S; Witzens M; Willhauck M; Waldmann V; Naeher H; Rammensee H G; Keilholz U
Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay.
International journal of cancer. Journal international du cancer 1997;71(6):932-6.
1997: Maryanski J L; Casanova J L; Falk K; Gournier H; Jaulin C; Kourilsky P; Lemonnier F A; Lüthy R; Rammensee H G; Rötzschke O; Servis C; López J A
The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized.
Human immunology 1997;54(2):117-28.
1997: de la Salle H; Houssaint E; Peyrat M A; Arnold D; Salamero J; Pinczon D; Stevanovic S; Bausinger H; Fricker D; Gomard E; Biddison W; Lehner P; UytdeHaag F; Sasportes M; Donato L; Rammensee H G; Cazenave J P; Hanau D; Tongio M M; Bonneville M
Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(10):4555-63.
1997: Lammert E; Arnold D; Nijenhuis M; Momburg F; Hämmerling G J; Brunner J; Stevanovic S; Rammensee H G; Schild H
The endoplasmic reticulum-resident stress protein gp96 binds peptides translocated by TAP.
European journal of immunology 1997;27(4):923-7.
1997: Scheibenbogen C; Lee K H; Mayer S; Stevanovic S; Moebius U; Herr W; Rammensee H G; Keilholz U
A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):221-6.
1997: Münz C; Holmes N; King A; Loke Y W; Colonna M; Schild H; Rammensee H G
Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells.
The Journal of experimental medicine 1997;185(3):385-91.
1996: Vartdal F; Johansen B H; Friede T; Thorpe C J; Stevanovic S; Eriksen J E; Sletten K; Thorsby E; Rammensee H G; Sollid L M
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
European journal of immunology 1996;26(11):2764-72.
1996: Mayer S; Scheibenbogen C; Lee K H; Keilholz W; Stevanovic S; Rammensee H G; Keilholz U
A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides.
Journal of immunological methods 1996;197(1-2):131-7.
1996: Dick T P; Ruppert T; Groettrup M; Kloetzel P M; Kuehn L; Koszinowski U H; Stevanovic S; Schild H; Rammensee H G
Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.
Cell 1996;86(2):253-62.
1996: Friede T; Gnau V; Jung G; Keilholz W; Stevanovic S; Rammensee H G
Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides.
Biochimica et biophysica acta 1996;1316(2):85-101.
1996: Groettrup M; Soza A; Eggers M; Kuehn L; Dick T P; Schild H; Rammensee H G; Koszinowski U H; Kloetzel P M
A role for the proteasome regulator PA28alpha in antigen presentation.
Nature 1996;381(6578):166-8.
1996: Lammert E; Arnold D; Rammensee H G; Schild H
Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
European journal of immunology 1996;26(4):875-9.
1996: Diehl M; Münz C; Keilholz W; Stevanovic S; Holmes N; Loke Y W; Rammensee H G
Nonclassical HLA-G molecules are classical peptide presenters.
Current biology : CB 1996;6(3):305-14.
1996: Steinle A; Falk K; Rötzschke O; Gnau V; Stevanovic S; Jung G; Schendel D J; Rammensee H G
Motif of HLA-B*3503 peptide ligands.
Immunogenetics 1996;43(1-2):105-7.
1995: Schild H; Grüneberg U; Pougialis G; Wallny H J; Keilholz W; Stevanovic S; Rammensee H G
Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules.
International immunology 1995;7(12):1957-65.
1995: Barouch D; Friede T; Stevanovic S; Tussey L; Smith K; Rowland-Jones S; Braud V; McMichael A; Rammensee H G
HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
The Journal of experimental medicine 1995;182(6):1847-56.
1995: Arnold D; Faath S; Rammensee H; Schild H
Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
The Journal of experimental medicine 1995;182(3):885-9.
1995: Malcherek G; Gnau V; Jung G; Rammensee H G; Melms A
Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
The Journal of experimental medicine 1995;181(2):527-36.
1995: Rammensee H G
Chemistry of peptides associated with MHC class I and class II molecules.
Current opinion in immunology 1995;7(1):85-96.
1995: Falk K; Rötzschke O; Takiguchi M; Gnau V; Stevanovic S; Jung G; Rammensee H G
Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behcet's disease.
International immunology 1995;7(2):223-8.
1995: Bamford A I; Douglas A; Friede T; Stevanovic S; Rammensee H G; Adair B M
Peptide motif of a cattle MHC class I molecule.
Immunology letters 1995;45(1-2):129-36.
1995: Rammensee H G; Friede T; Stevanoviíc S
MHC ligands and peptide motifs: first listing.
Immunogenetics 1995;41(4):178-228.
1995: Falk K; Rötzschke O; Takiguchi M; Gnau V; Stevanovic S; Jung G; Rammensee H G
Peptide motifs of HLA-B58, B60, B61, and B62 molecules.
Immunogenetics 1995;41(2-3):165-8.
1995: Falk K; Rötzschke O; Takiguchi M; Gnau V; Stevanovic S; Jung G; Rammensee H G
Peptide motifs of HLA-B38 and B39 molecules.
Immunogenetics 1995;41(2-3):162-4.
1994: Stevanovic S; Rammensee H G
Identification of T-cell epitopes using allele-specific ligand motifs.
Behring Institute Mitteilungen 1994;(95):7-13.
1994: Malcherek G; Gnau V; Stevanovic S; Rammensee H G; Jung G; Melms A
Analysis of allele-specific contact sites of natural HLA-DR17 ligands.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(3):1141-9.
1994: Vogt A B; Kropshofer H; Kalbacher H; Kalbus M; Rammensee H G; Coligan J E; Martin R
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(4):1665-73.
1994: Rammensee H G
How the quest to identify minor histocompatibility antigens led to something more important.
Behring Institute Mitteilungen 1994;(94):11-6.
1994: Falk K; Rötzschke O; Stevanovic S; Gnau V; Sparbier K; Jung G; Rammensee H G; Walden P
Analysis of a naturally occurring HLA class I-restricted viral epitope.
Immunology 1994;82(3):337-42.
1994: Rötzschke O; Falk K; Stevanovic S; Gnau V; Jung G; Rammensee H G
Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.
Immunogenetics 1994;39(1):74-7.
1994: Falk K; Rötzschke O; Stevanovic S; Jung G; Rammensee H G
Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.
Immunogenetics 1994;39(4):230-42.
1994: Falk K; Rötzschke O; Takiguchi M; Grahovac B; Gnau V; Stevanovic S; Jung G; Rammensee H G
Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules.
Immunogenetics 1994;40(3):238-41.
1994: Maier R; Falk K; Rötzschke O; Maier B; Gnau V; Stevanovic S; Jung G; Rammensee H G; Meyerhans A
Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.
Immunogenetics 1994;40(4):306-8.
1993: Falk K; Rötzschke O; Grahovac B; Schendel D; Stevanovic S; Gnau V; Jung G; Strominger J L; Rammensee H G
Allele-specific peptide ligand motifs of HLA-C molecules.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(24):12005-9.
1993: Deres K; Beck W; Faath S; Jung G; Rammensee H G
MHC/peptide binding studies indicate hierarchy of anchor residues.
Cellular immunology 1993;151(1):158-67.
1993: Malcherek G; Falk K; Rötzschke O; Rammensee H G; Stevanovic S; Gnau V; Jung G; Melms A
Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.
International immunology 1993;5(10):1229-37.
1993: Falk K; Rötzschke O; Faath S; Goth S; Graef I; Shastri N; Rammensee H G
Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL.
Cellular immunology 1993;150(2):447-52.
1993: Norda M; Falk K; Rötzschke O; Stevanovic S; Jung G; Rammensee H G
Comparison of the H-2Kk- and H-2Kkm1-restricted peptide motifs.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;14(2):144-9.
1993: Rötzschke O; Falk K; Stevanovic S; Grahovac B; Soloski M J; Jung G; Rammensee H G
Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules.
Nature 1993;361(6413):642-4.
1993: Falk K; Rötzschke O; Grahovac B; Schendel D; Stevanovic S; Jung G; Rammensee H G
Peptide motifs of HLA-B35 and -B37 molecules.
Immunogenetics 1993;38(2):161-2.
1992: Wallny H J; Deres K; Faath S; Jung G; Van Pel A; Boon T; Rammensee H G
Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant.
International immunology 1992;4(10):1085-90.
1992: Rötzschke O; Falk K; Stevanovic S; Jung G; Rammensee H G
Peptide motifs of closely related HLA class I molecules encompass substantial differences.
European journal of immunology 1992;22(9):2453-6.
1992: Falk K; Rötzschke O; Rammensee H G
Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man.
European journal of immunology 1992;22(5):1323-6.
1992: Falk K; Rötzschke O; Rammensee H G
A self peptide naturally presented by both H-2Kb and H-2Kbm1 molecules demonstrates MHC restriction of self tolerance at the molecular level.
International immunology 1992;4(3):321-5.
1992: Wallny H J; Rötzschke O; Falk K; Hämmerling G; Rammensee H G
Gene transfer experiments imply instructive role of major histocompatibility complex class I molecules in cellular peptide processing.
European journal of immunology 1992;22(3):655-9.
1991: Schild H; Norda M; Deres K; Falk K; Rötzschke O; Wiesmüller K H; Jung G; Rammensee H G
Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.
The Journal of experimental medicine 1991;174(6):1665-8.
1991: Rötzschke O; Falk K; Faath S; Rammensee H G
On the nature of peptides involved in T cell alloreactivity.
The Journal of experimental medicine 1991;174(5):1059-71.
1991: Schild H; Deres K; Wiesmüller K H; Jung G; Rammensee H G
Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells.
European journal of immunology 1991;21(11):2649-54.
1991: Rötzschke O; Falk K; Stevanovic S; Jung G; Walden P; Rammensee H G
Exact prediction of a natural T cell epitope.
European journal of immunology 1991;21(11):2891-4.
1991: Cerundolo V; Elliott T; Elvin J; Bastin J; Rammensee H G; Townsend A
The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules.
European journal of immunology 1991;21(9):2069-75.
1991: Falk K; Rötzschke O; Deres K; Metzger J; Jung G; Rammensee H G
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
The Journal of experimental medicine 1991;174(2):425-34.
1991: Griem P; Wallny H J; Falk K; Rötzschke O; Arnold B; Schönrich G; Hämmerling G; Rammensee H G
Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression.
Cell 1991;65(4):633-40.
1991: Falk K; Rötzschke O; Stevanovic S; Jung G; Rammensee H G
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
Nature 1991;351(6324):290-6.
1991: Rammensee H G
Maintenance of self tolerance in CD4+ T lymphocytes by antigen presentation on resting B cells--a hypothesis.
Bone marrow transplantation 1991;7 Suppl 1():26-8.
1990: Rötzschke O; Falk K; Deres K; Schild H; Norda M; Metzger J; Jung G; Rammensee H G
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.
Nature 1990;348(6298):252-4.
1990: Rötzschke O; Falk K; Wallny H J; Faath S; Rammensee H G
Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y.
Science (New York, N.Y.) 1990;249(4966):283-7.
1990: Schild H; Rötzschke O; Kalbacher H; Rammensee H G
Limit of T cell tolerance to self proteins by peptide presentation.
Science (New York, N.Y.) 1990;247(4950):1587-9.
1989: Deres K; Schild H; Wiesmüller K H; Jung G; Rammensee H G
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine.
Nature 1989;342(6249):561-4.
1989: Rammensee H G; Kroschewski R; Frangoulis B
Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.
Nature 1989;339(6225):541-4.
1989: Frangoulis B; Pla M; Rammensee H G
Alternative T cell receptor gene usage induced by self tolerance.
European journal of immunology 1989;19(3):553-5.
1989: Rammensee H G; Schild H; Theopold U
Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of beta-galactosidase.
Immunogenetics 1989;30(4):296-302.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hans-Georg Rammensee

Research Profile (preview)

Anatomy

Living Beings

Genes & Molecular Sequences

Concepts & Ideas

Chemicals & Drugs

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hans-Georg Rammensee (preview)

All Publications